INTERNATIONAL PATENT: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, UNIVERSITE PARIS-SACLAY FILES APPLICATION FOR "KYNURENINE-3-MONOOXYGENASE (KMO) INHIBITORS TO TREAT PULMONARY HYPERTENSION"

GENEVA, Jan. 5 -- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (101, rue de Tolbiac75013 Paris), UNIVERSITE PARIS-SACLAY (Batiment Breguet3 Rue Joliot Curie91190 Gif Sur Yvette) filed a patent application (PCT/EP2025/068404) for "KYNURENINE-3-MONOOXYGENASE (KMO) INHIBITORS TO TREAT PULMONARY HYPERTENSION" on Jun 27, 2025. With publication no. WO/2026/003352, the details related to the patent application was published on Jan 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): COHEN-KAMINSKY, Sylvia (Inserm UMR_S999, Universite Paris SaclayHopital Marie Lannelongue133 avenue de la...